image of Dovato's new blister pack package and box

Dovato now available in new packaging option

picture of the AIDS Quilt on display at the National Mall in Washington, D.C.

New documentary considers the last mile to ‘Ending HIV in America’

A upcoming PBS documentary, “Ending HIV in America,” recounts the history of the AIDS epidemic and looks at how far HIV prevention and treatment efforts have come.

Image of doctor holding digital tablet in modern hospital

The PROgress project

Preparing patients and doctors for their next visit enhances patient satisfaction and care

People in a crowd forming the shape of a finger turning on a power button

Being Bridgette

Humanizing science

medical research image

Report from the community HIV cure research workshop

HIV cure research highlights

picture of Marc Thompson

HIV and aging at CROI

‘There are many added layers and dimensions to consider’

resistance, pushing against oncoming arrows

The NADIA study

Second-line treatment recommendations

man holding up an at-home COVID-19 test

Virtual CROI 2022: Testing and treating

Highlights from Virtual CROI 2022

gilded portrait frame

When HIV therapy fails: Terms of ART

A treatment glossary

The web page of the DHHS HIV treatment guidelines appears on a tablet device being held by  hands

When HIV therapy fails: That’s not all, folks

An explanation of some of the technical language in the DHHS’ HIV treatment guidelines

illustration of a pair of hands opening a medicine bottle with a degree of difficulty

When HIV therapy fails: For treatment-experienced individuals who are experiencing virologic failure

Key considerations and recommendations from the HIV treatment guidelines of the U.S. Department of Health and Human Services (DHHS)

Water gushing from a broken pipe

When HIV therapy fails

Some basic information from U.S. treatment guidelines

three navel oranges with an increasingly large, prominent navel

Briefly May+Jun 2022

Cabenuva long-acting injectable no longer requires a month of oral lead-in medication

Investigational new drugs

Looking ahead

What’s on the horizon—new drugs in development

DHHS Recommendations

Guidelines for people starting HIV therapy for the first time


The people behind the 2022 HIV Drug Guide

FDA approves two-month shot of Cabenuva for HIV

FDA has approved Cabenuva, the long-acting injectable regimen, as a shot that can be taken every two months instead of monthly for HIV treatment

25 years of HAART

The long journey continues

Briefly Jan+Feb 2022

New injectable PrEP given every two months: Apretude

The Category Is: Virtual realness

Readers respond to questions about telehealth services

 A woman covering her eyes

Being Bridgette

As a woman

The Category Is Sep+Oct 2021

Basic Realness

Roadside assistance

HIV treatment can be costly, but there's help

HIV life cycle

Different drug classes interrupt the virus from replicating at various stages

12 things to know about HIV treatment

It is recommended that everyone living with HIV be on HIV treatment, and as soon as possible after diagnosis.

Getting around

In this guide, HIV drugs are grouped into eight categories —plus, additional categories for select non-HIV drugs and PrEP

DHHS Recommendations

DHHS Guidelines for people starting HIV therapy for the first time

Editor’s note Mar+Apr 2021

This issue of Positively Aware magazine is our 25th Annual HIV Drug Guide, and it’s been quite a ride.

A great love endures

Remembering the humility and joy of Timothy Ray Brown

Mind, body, and medicine

Taking care of your mental health while living with HIV

Stories of women remaking a life

Overcoming trauma and stigma to live free

The ‘London patient’ is only the second person to be ‘cured’ of HIV

Top news from AIDS2020: Virtual

Highlights from the AIDS2020: Virtual conference

Positively Aware: CROI 2020 Fatty Tissues

Fatty (t)issues

Weight gain and HIV medications

New long-acting drugs in development

Trend towards long-acting HIV medications continues

Taking meds monthly—or possibly once a year

A look at drugs in development for HIV treatment and prevention

Positively Aware: A sneak peak at new HIV meds in development

What's Cooking?

A sneak peak at some of the new drugs coming soon

2020 HIV Drug Chart

A quick guide to the most commonly used HIV medications

HIV Life Cycle

Different drug classes interrupt the virus from replicating at various stages

Choice Options

DHHS Guidelines for people starting HIV therapy for the first time

The Waxing and Waning of HIV Drugs

Medications come and go, but the goal is still the same

Weighty Concerns

What we know for now about weight gain with HIV medications


Our 2020 HIV Drug Guide Contributors


Pregnancy and dolutegravir; AIDS Quilt finds a new home; survey on women living with HIV; and more

The future is already here

Technological advances in HIV treatment and prevention

Truvada Safety

Queer Eye's Jonathan Van Ness


FDA approves Descovy for PrEP; Delstrigo and Pifeltro approved for switch treatment; Bictegravir, dolutegravir and Tybost for children; and more.

Exciting news from Mexico City

Fostemsavir; long-acting injectable; vaginal ring

Dolutegravir during pregnancy

Based on new data, the World Health Organization (WHO) recommended dolutegravir as a preferred HIV drug for all populations living with HIV, including pregnant women and those wanting to conceive.

HIV meds just four days a week?

And other conference highlights including new long-acting drug GS-6207; PrEP on demand; HIV treatment = prevention.

Building blocks for a healthy life

Building blocks for a healthy life, with insights from a nurse educator


Biktarvy and antacids. Descovy FDA hearing. Updated guidelines for transgender individuals. Biktarvy and kids. PrEP4Love. Michael Johnson freed.

Jeff Berry in 1989

Editor's Note

Note to my younger self.

Truvada Safety

Truvada Safety

Talking about PrEP and HIV treatment in a time of class action lawsuits

Positively Aware Briefly


Monthly injectable HIV med on the way; HIV pharma sued over pricing practices; Australian PrEP advocate talks about his new HIV status; ​​​​tenofovir class action lawsuits

Healthiness in HIV

A look in the poster hall

Drugs in development

Monthly injections plus inhibitors of viral capsid and maturation

Positively Aware Briefly

Briefly: May+June 2019

New two-drug regimen gets FDA approval. Transgender filmmaker debuts new documentary. Project Inform closes. First kidney transplant from donor living with HIV.

Positively Aware: An A to Z listing of the medications in the 2019 HIV Drug Guide.

Find Your 2020 HIV Drug Here

An A to Z listing of the drugs in the 2020 HIV Drug Guide

Coming Attractions

A sneak peak at some of the new drugs coming soon

An Ensemble Cast

How different drug classes play their part in the HIV lifecycle

Your Map to the Stars

Getting the most out of your drug guide

On With the Show!

Moving beyond your diagnosis—finding a provider, knowing your rights, and more

Supporting Role

HIV treatment can be costly, but there’s help

When Drugs Collide!

Understanding drug interactions

Positively Aware: Rising to the occasion

Rising to the Occasion

DHHS guideline recommendations for first-time therapy in HIV

And the Nominees Are…

A quick look at the recommendations for first-time therapy

Positively Aware The Conversation

The Conversation: March & April 2019

Mixed emotions for a long-term survivor. Peer education in prison. Loving the HIV drug guides and charts. 

Opening Credits

Contributors to the 2019 HIV Drug Guide

Front Cover Backstory: March & April 2019

The experience is your own, but you’re not alone in the room

The road ahead

New drugs, new options on the horizon

Pennies from above

HIV treatment can be costly, but there’s help

Standard practice

DHHS treatment guidelines for first-time HIV therapy

The future of HIV therapy

New strategies are here—and more are on the way, says W. David Hardy, MD